BioCentury
ARTICLE | Clinical News

MIV-711: Phase IIa ongoing

October 10, 2016 7:00 AM UTC

An IDMC recommended continuation of the double-blind, placebo-controlled, European Phase IIa MIV-711-201 trial of oral MIV-711 based on safety data from 50 patients with knee joint OA who completed 3 ...